Verition Fund Management’s AstraZeneca AZN Stock Holding History

Verition Fund Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$948K	Buy	+5,000	New	+$940K	﹤0.01%	1436
2022 Q1	–	Sell	-61,100	Closed	-$7.12M	–	2715
2021 Q4	$7.12M	Sell	61,100 -80,400	-57%	-$9.46M	0.05%	249
2021 Q3	$17M	Sell	141,500 -34,200	-19%	-$3.98M	0.15%	102
2021 Q2	$21M	Buy	175,700 +7,950	+5%	+$872K	0.19%	80
2021 Q1	$16.7M	Buy	167,750 +125,250	+295%	+$12.6M	0.19%	75
2020 Q4	$4.25M	Buy	+42,500	New	+$4.5M	0.04%	229

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Verition Fund Management's AZN Position: Q2 2026 in Review

Verition Fund Management opened a new position in AstraZeneca (AZN) in Q2 2026: 12,704 shares worth $2.41M. The stake represents 0.01% of the portfolio and ranks #1016 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in AZN as recently as Q4 2025.

Verition Fund Management first reported a position in AZN in Q2 2013 and has held it in 24 quarters since. The position peaked at $160M in Q3 2021. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Verition Fund Management held 12,704 shares of AstraZeneca worth $2.41M as of Q2 2026.
AstraZeneca was a new Verition Fund Management position in Q2 2026.
AstraZeneca made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1016 holding.
Verition Fund Management first reported a position in AstraZeneca in Q2 2013 and has held it in 24 quarters since.
Verition Fund Management's AstraZeneca position peaked at $160M in Q3 2021.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.